Insider · CIK 0001910331

DOYLE THOMAS JAMES

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001910331

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-28	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−4,607 sh	$10.50	−$48.4K	142,428
2026-01-27	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−881 sh	$8.46	−$7,453.877	145,167
2026-01-27	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−2,226 sh	$8.46	−$18.8K	146,048
2026-01-27	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−695 sh	$8.46	−$5,880.187	148,274
2026-01-27	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−1,114 sh	$8.46	−$9,425.22	148,969
2026-01-27	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−2,226 sh	$8.46	−$18.8K	150,083
2026-01-02	KURAKura Oncology, Inc. · Option to purchase common stockA Award	SVP, Finance & Accounting	AAward	+42.5K sh	—	—	42,500
2026-01-02	KURAKura Oncology, Inc.A Award	SVP, Finance & Accounting	AAward	+21.3K sh	—	—	152,309
2025-11-14	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−4,539 sh	$11.18	−$50.7K	130,257
2025-11-13	KURAKura Oncology, Inc.A Award	SVP, Finance & Accounting	AAward	+25K sh	—	—	134,796
2025-09-29	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−4,541 sh	$8.94	−$40.6K	109,829
2025-09-27	KURAKura Oncology, Inc.A Award	SVP, Finance & Accounting	AAward	+25K sh	—	—	114,370
2025-01-28	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−1,122 sh	$7.87	−$8,832.272	88,193
2025-01-28	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−699 sh	$7.87	−$5,502.458	89,315
2025-01-28	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−887 sh	$7.87	−$6,982.375	90,014
2025-01-28	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−2,241 sh	$7.87	−$17.6K	90,901
2025-01-02	KURAKura Oncology, Inc. · Option to purchase common stockA Award	SVP, Finance & Accounting	AAward	+42.5K sh	—	—	42,500
2025-01-02	KURAKura Oncology, Inc.A Award	SVP, Finance & Accounting	AAward	+21.3K sh	—	—	71,892
2025-01-02	KURAKura Oncology, Inc.A Award	SVP, Finance & Accounting	AAward	+21.3K sh	—	—	93,142
2024-01-29	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−594 sh	$17.80	−$10.6K	49,817
2024-01-29	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−963 sh	$17.80	−$17.1K	48,093
2024-01-29	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−761 sh	$17.80	−$13.5K	49,056
2024-01-02	KURAKura Oncology, Inc. · Option to purchase common stockA Award	SVP, Finance & Accounting	AAward	+42.5K sh	—	—	42,500
2024-01-02	KURAKura Oncology, Inc.A Award	SVP, Finance & Accounting	AAward	+21.3K sh	—	—	50,411
2023-02-16	KURAKura Oncology, Inc. · Option to purchase common stockA Award	SVP, Finance & Accounting	AAward	+63.8K sh	—	—	63,750
2023-02-16	KURAKura Oncology, Inc.A Award	SVP, Finance & Accounting	AAward	+10.6K sh	—	—	27,466
2023-01-27	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−866 sh	$13.89	−$12K	16,841
2023-01-27	KURAKura Oncology, Inc.S Sale	SVP, Finance & Accounting	SSale	−682 sh	$13.89	−$9,472.844	17,707
2022-02-07	KURAKura Oncology, Inc.A Award	SVP, Finance & Accounting	AAward	+8,390 sh	—	—	15,000
2022-02-07	KURAKura Oncology, Inc. · Option to purchase common stockA Award	SVP, Finance & Accounting	AAward	+39.3K sh	—	—	39,281

Recent filings

Accepted (ET)
Sep 294
DOYLE THOMAS JAMES0001193125-26-407936
SEC(opens sec.gov)
Jan 274
DOYLE THOMAS JAMES0001193125-26-025302
SEC(opens sec.gov)
Jan 64
DOYLE THOMAS JAMES0001193125-26-004569
SEC(opens sec.gov)
Nov 144
DOYLE THOMAS JAMES0001193125-25-283562
SEC(opens sec.gov)
Sep 294
DOYLE THOMAS JAMES0001193125-25-223662
SEC(opens sec.gov)
Jan 284
DOYLE THOMAS JAMES0000950170-25-010137
SEC(opens sec.gov)
Jan 64
DOYLE THOMAS JAMES0000950170-25-002072
SEC(opens sec.gov)
Jan 314
DOYLE THOMAS JAMES0000950170-24-009496
SEC(opens sec.gov)

Companies

Kura Oncology, Inc.SVP, Finance & AccountingKURA

Address

C/O KURA ONCOLOGY, INC. 4930 DIRECTORS PLACE, SUITE 500

SAN DIEGO, CA, 92121